BFLY vs. ACRS

Last updated Apr 1, 2026

Compare and contrast key facts about Butterfly Network, Inc. (BFLY) and Aclaris Therapeutics, Inc. (ACRS).

Performance

BFLY vs. ACRS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Butterfly Network, Inc. (BFLY) and Aclaris Therapeutics, Inc. (ACRS). The values are adjusted to include any dividend payments, if applicable.

BFLY vs. ACRS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
BFLY Butterfly Network, Inc.	6.32%	21.79%	188.89%	-56.10%	-63.23%	-66.20%	99.90%
ACRS Aclaris Therapeutics, Inc.	24.58%	21.37%	136.19%	-93.33%	8.32%	124.73%	225.13%

Fundamentals

Market Cap BFLY : $1.02B ACRS : $459.99M
EPS BFLY : -$0.31 ACRS : -$0.53
PS Ratio BFLY : 10.30 ACRS : 58.76
PB Ratio BFLY : 5.21 ACRS : 4.46
Total Revenue (TTM) BFLY : $97.61M ACRS : $7.83M
Gross Profit (TTM) BFLY : $45.74M ACRS : $5.74M
EBITDA (TTM) BFLY : -$71.01M ACRS : -$71.59M

Returns By Period

In the year-to-date period, BFLY achieves a 6.32% return, which is significantly lower than ACRS's 24.58% return.

BFLY

• 1D: 5.48%
• 1M: 6.60%
• YTD: 6.32%
• 6M: 109.33%
• 1Y: 77.19%
• 3Y*: 29.04%
• 5Y*: -24.32%
• 10Y*: —

ACRS

• 1D: 7.45%
• 1M: 30.66%
• YTD: 24.58%
• 6M: 97.37%
• 1Y: 145.10%
• 3Y*: -22.61%
• 5Y*: -32.37%
• 10Y*: -15.62%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BFLY vs. ACRS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BFLY

BFLY Risk / Return Rank: 71
BFLY Sharpe Ratio Rank: 67
BFLY Sortino Ratio Rank: 78
BFLY Omega Ratio Rank: 72
BFLY Calmar Ratio Rank: 70
BFLY Martin Ratio Rank: 67

ACRS

ACRS Risk / Return Rank: 87
ACRS Sharpe Ratio Rank: 83
ACRS Sortino Ratio Rank: 90
ACRS Omega Ratio Rank: 85
ACRS Calmar Ratio Rank: 89
ACRS Martin Ratio Rank: 87

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BFLY vs. ACRS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Butterfly Network, Inc. (BFLY) and Aclaris Therapeutics, Inc. (ACRS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BFLY	ACRS	Difference
Sharpe ratio Return per unit of total volatility	0.73	1.48	-0.75
Sortino ratio Return per unit of downside risk	1.97	2.86	-0.89
Omega ratio Gain probability vs. loss probability	1.23	1.33	-0.11
Calmar ratio Return relative to maximum drawdown	1.43	3.71	-2.28
Martin ratio Return relative to average drawdown	2.98	9.22	-6.24
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BFLY vs. ACRS - Sharpe Ratio Comparison

The current BFLY Sharpe Ratio is 0.73, which is lower than the ACRS Sharpe Ratio of 1.48. The chart below compares the historical Sharpe Ratios of BFLY and ACRS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BFLY	ACRS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.73	1.48	-0.75
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.25	-0.35	+0.10
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.14	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.15	-0.09	-0.06

Correlation

The correlation between BFLY and ACRS is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BFLY vs. ACRS - Dividend Comparison

Neither BFLY nor ACRS has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

BFLY vs. ACRS - Drawdown Comparison

The maximum BFLY drawdown since its inception was -97.40%, roughly equal to the maximum ACRS drawdown of -98.05%. Use the drawdown chart below to compare losses from any high point for BFLY and ACRS.

Drawdown Indicators

	BFLY	ACRS	Difference
Max Drawdown Largest peak-to-trough decline	-97.40%	-98.05%	+0.65%
Max Drawdown (1Y) Largest decline over 1 year	-49.43%	-36.64%	-12.79%
Max Drawdown (5Y) Largest decline over 5 years	-95.90%	-97.82%	+1.92%
Max Drawdown (10Y) Largest decline over 10 years	—	-98.05%	—
Current Drawdown Current decline from peak	-85.11%	-88.63%	+3.52%
Average Drawdown Average peak-to-trough decline	-75.73%	-63.24%	-12.49%
Ulcer Index Depth and duration of drawdowns from previous peaks	23.68%	14.74%	+8.94%

Volatility

BFLY vs. ACRS - Volatility Comparison

Butterfly Network, Inc. (BFLY) and Aclaris Therapeutics, Inc. (ACRS) have volatilities of 22.01% and 21.82%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BFLY	ACRS	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.01%	21.82%	+0.19%
Volatility (6M) Calculated over the trailing 6-month period	85.38%	75.64%	+9.74%
Volatility (1Y) Calculated over the trailing 1-year period	106.84%	98.72%	+8.12%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	97.51%	92.46%	+5.05%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	95.29%	110.42%	-15.13%

Financials